Systemic near-fatal anaphylactic reaction after intrathecal methotrexate administration

Medical and Pediatric Oncology

Volumn 34, Issue 2, 2000, Pages 151-152

  Devecioǧlu, Ömer ^a,b   Biner, Betül ^a   Karaböcüoǧlu, Metin ^a   Ünüvar, Ayşegül ^a   Aǧaoǧlu, Leyla ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Acute lymphoblastic leukemia; Intrathecal methotrexate; Systemic anaphylactic reaction

Indexed keywords

METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANAPHYLAXIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; HUMAN; MALE; PRIORITY JOURNAL;

ANAPHYLAXIS; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; HUMANS; INJECTIONS, SPINAL; MALE; METHOTREXATE;

EID: 0033950298     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200002)34:2<151::AID-MPO17>3.0.CO;2-V     Document Type: Article

References (20)

1. Weiss RB, Bruno S. Hypersensitivity reactions to cancer chemotherapeutic agents. Ann Intern Med 1981;94:66-72.
2. Alkins SA, Byrd JC, Morgan SK, et al. Anaphylactoid reactions to methotrexate. Cancer 1996;77:2123-2126.
3. Goldberg NH, Romolo JL, Austin EH, et al. Anaphylactoid type reactions in two patients receiving high dose intravenous methotrexate. Cancer 1978;41:52-55.
4. Skullerud K, Halvorsen K. Encephalomyelopathy following intrathecal methotrexate treatment in a child with acute leukemia. Cancer 1978;42:1211-1215.
5. Bleyer WA, Drake JC, Chabner BA. Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med 1973;89:770-773.
6. Goldberg ID, Bloomer WD, Dawson DM. Nervous system toxic effects of cancer therapy. JAMA 1982;247:1437-1441.
7. Duttera MJ, Bleyer WA, Pomeray TC, et al. Irradiation, methotrexate toxicity and the treatment of meningeal leukemia. Lancet 1973;2:703-707.
8. Ten Hoeve RF, Twijnstra A. A lethal neurotoxic reaction after intraventricular methotrexate administration. Cancer 1988;62: 2111-2113.
9. Shapiro WR, Young DF, Mehta BP. Methotrexate: distribution in cerebrospinal fluid after intravenous,ventricular and lumbar injections. N Engl J Med 1975;293:161-166.
10. Mott MG, Stevenson P, Wood CB. Methotrexate meningitis. Lancet 1972;2:656.
11. Saiki JH, Thompson S, Smith F, Atkinson R. Paraplegia following intrathecal chemotherapy. Cancer 1972;29:370-374.
12. Garcia Tena J, Lopez Andreu JA, Ferris J, et al. Intrathecal chemotherapy related myeloencephalopathy in a young child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1995;12: 377-385.
13. Price RA, Jamieson PA. The central nervous in childhood leukemia: II. Subacute leukoencephalopathy. Cancer 1978;42:717-728.
14. Weiss RB. Hypersensitivity reactions. Semin Oncol 1992;19:458-477.
15. Al-Lamki Z, Thomas E, el-Banna N, et al. Acute urticaria and hepatitis complicating high-dose methotrexate therapy. Med Pediatr Oncol 1995;24:137-140.
16. Van Scott EJ, Auerbach R, Weinstein GD. Parenteral methotrexate in psoriasis. Arch Dermatol 1964;89:550-556.
17. Weinstein GD, Frost P, Fla M. Methotrexate for psoriasis. Arch Dermatol 1971;103:33-38.
18. Vega A, Cabonas R, Contera J, et al. Anaphylaxis to methotrexate: a possible IgE mediated mechanism. J Alleg Clin Immunol 1994; 94:268-270.
19. da Costa M, Isacoff W, Rothenberg SP, Iqbal P. Protein methotrexate-IgG complexes in the serum of patients receiving high-dose antifolate therapy. Cancer 1980;46:471-474.
20. Back EH. Death after intrathecal methotrexate. Lancet 1969;2: 1005.